Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Diseasesort ascending Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody UCSD
Development Candidate, Proof of Concept
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Kidney Failure Adult Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
IPEX Syndrome,
Immune Disease
Vital Research Opportunity Gene Therapy, cell free Stanford
IND
Intestinal Disease,
Neurological Disorders
iPS Cell Donor cell therapy CHLA
Pre-IND/IDE or Equivalent
Immune Disease,
Leukocyte Adhesion Deficiency
Adult Stem Cell Gene-modified, personalized cell therapy Rocket Pharmaceuticals, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy Orchard Therapeutics
Clinical Trial, Phase 2
Immune Disease,
X-linked Chronic Granulomatous Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Hyper IgM Syndrome,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Huntington's Disease Embryonic Stem Cell Donor cell therapy UC Irvine
IND
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS Personalized cell therapy COH
IND
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
HIV-related Lymphoma,
HIV/AIDS
Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Hemophilia A Adult Stem Cell Gene modification COH
Development Candidate, Proof of Concept
Hearing Loss iPS Cell Model system development USC
Proof of Concept, Tool/Resources/Bottleneck
Hearing Loss Adult Stem Cell Protein/peptide therapy Stanford
Development Candidate, Proof of Concept
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Pre-IND/IDE or Equivalent
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Research Insights
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Cystinosis,
Kidney Failure
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Clinical Trial, Phase 1 or Phase 1/2
COVID-19 Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 2
COVID-19 Adult Stem Cell Small molecule therapy Stanford
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Vaccine Stanford
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Gene-modified, donor cell therapy COH
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Vaccine UCLA
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Small molecule therapy UCLA
Pre-IND/IDE or Equivalent
COVID-19,
Respiratory Disorders
Adult Stem Cell Donor cell therapy Celularity Inc
Clinical Trial, Phase 1 or Phase 1/2
COVID-19,
Respiratory Disorders
iPS Cell Gene-modified, donor cell therapy USC
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy Sanford-Burnham
Development Candidate, Proof of Concept
COVID-19 iPS Cell Cell delivery or targeting UCSD
Tool/Resources/Bottleneck
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
Adult Stem Cell Model system development UCLA
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck
COVID-19,
Respiratory Disorders
Adult Stem Cell Biologic UCSD
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
Vital Research Opportunity Convalescent Plasma COH
Clinical Trial, Phase 1 or Phase 1/2
COVID-19 Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy USC
Development Candidate, Proof of Concept
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Colon Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Heart Disease,
Danon Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Development Candidate, Proof of Concept
Heart Disease iPS Cell Personalized cell therapy UC Davis
Proof of Concept
Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Cancer Cancer Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Canavan Disease iPS Cell Gene-modified, personalized cell therapy COH
Pre-IND/IDE or Equivalent
Brain Injury, hypoxic, ischemic Adult Stem Cell Donor cell therapy Sanford-Burnham
Pre-IND/IDE or Equivalent
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2

Pages

Icon for csv export